placeholder image
P Zhang All authors
About
Publications While At HealthPartners
selected publications
Journal Article
  • Depatuxizumab mafodotin in EGFR-amplified newly diagnosed glioblastoma: a phase III randomized clinical trial. 
    Neuro-Oncology. 2023
  • Intranasal delivery of nanoliposomal SN-38 for treatment of diffuse midline glioma. 
    Journal of Neurosurgery. 2022
  • Baseline comparison of three health utility measures and the feeling thermometer among participants in the Action to Control Cardiovascular Risk in Diabetes trial. 
    Cardiovascular Diabetology. 2012
  • Glycaemia and correlates of patient-reported outcomes in ACCORD trial participants. 
    Diabetic Medicine. 2012
  • Effect of intensive glycemic lowering on health-related quality of life in type 2 diabetes: ACCORD trial. 
    Diabetes care. 2011
  • Health-related quality of life and cost-effectiveness components of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: rationale and design Am J Cardiol
    2007
    • Review
  • Economic evaluation of combined diet and physical activity promotion programs to prevent type 2 diabetes among persons at increased risk: a systematic review for the Community Preventive Services Task Force [review, systematic review]. 
    Annals of Internal Medicine. 2015
    • Abstract
  • Long-term impact of intensive glucose, blood pressure, or lipid control on health utility: ACCORDION Study [abstract]. 
    Diabetes. 2016
  • Costs associated with delivering intensive or standard glucose, lipids, and systolic blood pressure control strategies in the ACCORD Trial [abstract]. 
    Diabetes. 2013
  • Intensive glucose, blood pressure, or lipid control had no significant negative impact on health utility or quality-adjusted life years in the ACCORD Trial [abstract]. 
    Diabetes. 2012
    • Contact
    full name
  • P Zhang
  • P. Zhang
    • Quick Info
     
    Collaboration